[go: up one dir, main page]

IL138127A - Process for the synthesis of hiv protease inhibitors - Google Patents

Process for the synthesis of hiv protease inhibitors

Info

Publication number
IL138127A
IL138127A IL13812799A IL13812799A IL138127A IL 138127 A IL138127 A IL 138127A IL 13812799 A IL13812799 A IL 13812799A IL 13812799 A IL13812799 A IL 13812799A IL 138127 A IL138127 A IL 138127A
Authority
IL
Israel
Prior art keywords
synthesis
protease inhibitors
hiv protease
hiv
inhibitors
Prior art date
Application number
IL13812799A
Other languages
English (en)
Other versions
IL138127A0 (en
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of IL138127A0 publication Critical patent/IL138127A0/xx
Publication of IL138127A publication Critical patent/IL138127A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/18—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/20—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
IL13812799A 1998-03-20 1999-03-18 Process for the synthesis of hiv protease inhibitors IL138127A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9805898.5A GB9805898D0 (en) 1998-03-20 1998-03-20 Process for the sythesis of hiv protease inhibitors
PCT/GB1999/000852 WO1999048885A1 (en) 1998-03-20 1999-03-18 Process for the synthesis of hiv protease inhibitors

Publications (2)

Publication Number Publication Date
IL138127A0 IL138127A0 (en) 2001-10-31
IL138127A true IL138127A (en) 2003-10-31

Family

ID=10828884

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13812799A IL138127A (en) 1998-03-20 1999-03-18 Process for the synthesis of hiv protease inhibitors

Country Status (31)

Country Link
US (1) US6281367B1 (xx)
EP (1) EP1066276B1 (xx)
JP (1) JP3363439B2 (xx)
KR (1) KR100555278B1 (xx)
CN (1) CN1308319C (xx)
AP (1) AP1226A (xx)
AT (1) ATE242772T1 (xx)
AU (1) AU751534B2 (xx)
BR (1) BR9908970A (xx)
CA (1) CA2324217C (xx)
CZ (1) CZ299193B6 (xx)
DE (1) DE69908761T2 (xx)
DK (1) DK1066276T3 (xx)
EA (1) EA003022B1 (xx)
EE (1) EE04750B1 (xx)
ES (1) ES2203090T3 (xx)
GB (1) GB9805898D0 (xx)
HR (1) HRP20000609B1 (xx)
HU (1) HUP0105439A3 (xx)
ID (1) ID26587A (xx)
IL (1) IL138127A (xx)
IS (1) IS2273B (xx)
NO (1) NO317648B1 (xx)
NZ (1) NZ506563A (xx)
PL (1) PL201810B1 (xx)
PT (1) PT1066276E (xx)
RS (1) RS49954B (xx)
SK (1) SK283939B6 (xx)
TR (1) TR200002698T2 (xx)
WO (1) WO1999048885A1 (xx)
ZA (1) ZA200004482B (xx)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2177868T3 (es) 1992-08-25 2002-12-16 Searle & Co Hidroxietilaminosulfonamidas de alfa- y beta-aminoacidos utiles como inhibidores de proteasas retroviricas.
DE60039533D1 (de) * 1999-12-23 2008-08-28 Ampac Fine Chemicals Llc Verbessertes verfahren zur herstellung von 2s,3s-n-isobutyl-n-(2-hydroxy-3-amino-4-phenylbutyl)-p-nitrobenzenesulfonylamid hydrochlorid und anderen derivaten von 2-hydroxy-1,3-diamin
US6548706B2 (en) * 1999-12-23 2003-04-15 Aerojet Fine Chemicals Llc Preparation of 2S,3S-N-isobutyl-N-(2-hydroxy-3-amino-4-phenylbutyl) -p-nitrobenzenesulfonylamide hydrochloride and other derivatives of 2-hydroxy-1,3-diamines
CA2485834C (en) 2002-05-16 2007-07-17 Tibotec Pharmaceuticals Ltd. Pseudopolymorphic forms of a hiv protease inhibitor
DK1725566T3 (da) * 2003-12-23 2009-10-05 Tibotec Pharm Ltd Fremgangsmåde til fremstilling af (3R,3AS, 6AR)-hexahydrofuro [2,3.B] furan-3-yl (1S,2R)-3-3[[(4-aminophenyl) sulfonyl] (isobutyl) amino]-1-benzyl-2-hydroxypropylcarbamat
JP4818124B2 (ja) * 2003-12-23 2011-11-16 テイボテク・フアーマシユーチカルズ・リミテツド （３Ｒ，３ａＳ，６ａＲ）−ヘキサヒドロフロ〔２，３−ｂ〕フラン−３−イル（１Ｓ，１Ｒ）−３−〔〔（４−アミノフェニル）スルホニル〕（イソブチル）アミノ〕−１−ベンジル−２−ヒドロキシプロピルカルバマートの製造方法
TWI482775B (zh) 2008-09-01 2015-05-01 Tibotec Pharm Ltd 用於製備（３ｒ，３ａｓ，６ａｒ）－六氫呋喃并〔２，３－ｂ〕呋喃－３－基（１ｓ，２ｒ）－３－〔〔（４－胺基苯基）磺醯基〕（異丁基）胺基〕－１－苯甲基－２－羥基丙基胺基甲酸酯之方法
PH12012501537A1 (en) 2010-01-27 2018-02-07 Viiv Healthcare Co Antiviral therapy
US8877947B2 (en) 2010-09-10 2014-11-04 Lupin Limited Process for preparation of substantially pure fosamprenavir calcium and its intermediates
CN111233794A (zh) * 2020-03-27 2020-06-05 江巨东 一种安普那韦的精制方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1071930A (zh) * 1991-07-10 1993-05-12 伊莱利利公司 用作治疗艾滋病的人免疫缺陷病毒蛋白酶的抑制剂
ES2177868T3 (es) * 1992-08-25 2002-12-16 Searle & Co Hidroxietilaminosulfonamidas de alfa- y beta-aminoacidos utiles como inhibidores de proteasas retroviricas.
US5723490A (en) * 1992-09-08 1998-03-03 Vertex Pharmaceuticals Incorporated THF-containing sulfonamide inhibitors of aspartyl protease
IS2334B (is) * 1992-09-08 2008-02-15 Vertex Pharmaceuticals Inc., (A Massachusetts Corporation) Aspartyl próteasi hemjari af nýjum flokki súlfonamíða

Also Published As

Publication number Publication date
CA2324217A1 (en) 1999-09-30
NO20004664L (no) 2000-09-19
IS2273B (is) 2007-07-15
KR100555278B1 (ko) 2006-03-03
ATE242772T1 (de) 2003-06-15
DE69908761D1 (de) 2003-07-17
CN1293668A (zh) 2001-05-02
GB9805898D0 (en) 1998-05-13
RS49954B (sr) 2008-09-29
CZ299193B6 (cs) 2008-05-14
EE200000568A (et) 2002-02-15
AP2000001911A0 (en) 2000-09-30
NZ506563A (en) 2003-05-30
HK1032047A1 (en) 2001-07-06
EA003022B1 (ru) 2002-12-26
PT1066276E (pt) 2003-10-31
PL342602A1 (en) 2001-06-18
SK283939B6 (sk) 2004-05-04
DE69908761T2 (de) 2004-02-19
WO1999048885A1 (en) 1999-09-30
YU55900A (sh) 2003-02-28
AP1226A (en) 2003-11-21
TR200002698T2 (tr) 2000-12-21
DK1066276T3 (da) 2003-10-06
EP1066276B1 (en) 2003-06-11
HRP20000609A2 (en) 2001-04-30
AU2947599A (en) 1999-10-18
AU751534B2 (en) 2002-08-22
SK13732000A3 (sk) 2001-08-06
NO20004664D0 (no) 2000-09-19
HRP20000609B1 (en) 2006-05-31
PL201810B1 (pl) 2009-05-29
ES2203090T3 (es) 2004-04-01
JP3363439B2 (ja) 2003-01-08
IS5605A (is) 2000-08-29
HUP0105439A3 (en) 2002-08-28
IL138127A0 (en) 2001-10-31
EA200000859A1 (ru) 2001-04-23
KR20010042022A (ko) 2001-05-25
ID26587A (id) 2001-01-18
ZA200004482B (en) 2001-11-28
BR9908970A (pt) 2000-11-28
NO317648B1 (no) 2004-11-29
EE04750B1 (et) 2006-12-15
JP2002507609A (ja) 2002-03-12
EP1066276A1 (en) 2001-01-10
CZ20003457A3 (cs) 2001-04-11
CN1308319C (zh) 2007-04-04
HUP0105439A2 (en) 2002-06-29
CA2324217C (en) 2008-02-19
US6281367B1 (en) 2001-08-28

Similar Documents

Publication Publication Date Title
AU3662799A (en) Processes for the synthesis of oligomeric compounds
PL342113A1 (en) Sulphonamidic derivatives useful as precursors of aspartil protease inhibitors
AU1601100A (en) Improved processes for the synthesis of oligomeric compounds
GB0017173D0 (en) Process for the production of olefins
EP1067894A4 (en) PROTHEASEINHIBITOREN
IL133363A (en) Process for the production of herapin
AP2000001911A0 (en) Process for the synthesis of hiv protease inhibitors
HUP0003593A3 (en) Process to produce 4-hydroxy-2-oxo-pyrane derivatives useful as protease inhibitors
EP1079821A4 (en) PROTEASE INHIBITORS
GB9515802D0 (en) Hiv protease inhibitors useful for the treatment of aids
IL123014A0 (en) Process for the production of halogeno-o-hydroxydiphenyl compounds
ZA945234B (en) Process for making HIV protease inhibitors
IL124178A (en) Process for the production of distryryl-biphenyl compounds
IL138843A0 (en) Improved process for the manufacture of n- (1-cyanoalkyl) -2-phenoxypropionamide derivatives
SI1066276T1 (en) Process for the synthesis of hiv protease inhibitors
AU1611900A (en) Process for the synthesis of quinazolinones
GB9825179D0 (en) Process for the removal of organometallic materials
HUP0203214A3 (en) Process for preparing intermediates applicable for synthesis of hiv protease inhibitor
HUP0103105A3 (en) Process for the synthesis of exochelins
AU6774201A (en) Process for the production of olefins
IL151043A0 (en) Process for the selective n-formylation of n-hydroxylamines
HUP0302387A3 (en) Process for the preparation of protected 1-(1-aminoalkyl)-oxiranes
IL136026A0 (en) Process for the production of formylimidazoles
AU3515700A (en) Process for the synthesis of dihydropyridones
GB9609663D0 (en) HIV Protease inhibitors useful for the treatment of aids

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees